drugset / Trial / NCT00308919

Study of Photodynamic Therapy in Patients With Prostate Cancer Following Radiation Therapy

NCT00308919 ↗

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To assess by MR Imaging the lesions induced by WST09-mediated photodynamic therapy (PDT) in patients with recurrent or persistent localized prostate cancer following definitive radiotherapy using different light doses and multiple illuminating fibres.

Timeline

Start
2004-04
Primary completion
—
Completion
2005-11

Drugs

EvaluationDrugModalityDoseRoute
Subject TOOKAD Other / unclassified — Intravenous

Indications